Cargando…
Remimazolam Compared to Propofol During Hysteroscopy: A Safety and Efficacy Analysis
INTRODUCTION: Propofol is the main drug used to induce sedation for endoscopic procedures, and few drugs had shaken its dominant clinical use for a decade until the development of remimazolam. Remimazolam has been demonstrated to perform well in post-marketing studies on sedation for colonoscopy or...
Autores principales: | Fan, Shunyi, Zhu, Yun, Sui, Changzhong, Li, Qian, Jiang, Wenxin, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199972/ https://www.ncbi.nlm.nih.gov/pubmed/36905564 http://dx.doi.org/10.1007/s40122-023-00483-4 |
Ejemplares similares
-
Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial
por: Zhang, Xiaoqiang, et al.
Publicado: (2021) -
Remimazolam Tosylate Combined with Low-Dose Propofol Improves Sedation and Safety in Hysteroscopy
por: Zhang, Fan, et al.
Publicado: (2022) -
Correction to: Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial
por: Zhang, Xiaoqiang, et al.
Publicado: (2021) -
Determination of the 50% and 95% Effective Dose of Remimazolam Combined with Propofol for Intravenous Sedation During Day-Surgery Hysteroscopy
por: Tan, Hua, et al.
Publicado: (2023) -
Remimazolam-remifentanil causes less postoperative nausea and vomiting than remimazolam-alfentanil during hysteroscopy: a single-centre randomized controlled trial
por: Zhang, Xiaoqiang, et al.
Publicado: (2023)